InvestorsHub Logo
icon url

HALF FULL GLASS

07/21/09 4:54 PM

#21015 RE: mata hari #21012

Mata,
How couild that be?

Why would a poster who holds no stock? want to sway the readers in two distinctly different directions at two different times?

What motive could possibly be in place?

How can one poster Go from,"I have done extensive research into the technology that RECAF uses and it WORKS."
To...then state,"I know enough about RECAF to swear on a mile high stack of bibles that I would never buy another share of this stock."

From,"Dr. Moro will go down in history as one of the leading developers of cancer detection and treatment."
To.."Moro has made several claims that have failed to materialize."

From,"The personalization aspect of the test is huge."
To.."There is no market for Recaf"

From,"Researchers are developing treatments that use the same technology so it does not really matter where the cancer is."
To..."If you don't know where the cancer is, the test is no good"




"Dakota, I have done extensive research into the technology that RECAF uses and it WORKS. It will be a huge seller and IMO, look for some data to be presented at the July 24th conference in a presentation by the lead developer of the RECAF test at Abbott. Dr. Moro will go down in history as one of the leading developers of cancer detection and treatment.

The personalization aspect of the test is huge. Any developing cancer will cause your RECAF level to dramatically increase. It detects the level of cancer cell division so any change in your normal level is a RED ALERT. Researchers are developing treatments that use the same technology so it does not really matter where the cancer is."

icon url

HALF FULL GLASS

07/21/09 5:43 PM

#21017 RE: mata hari #21012

37th ISOBM Congress 2009 Amsterdam
September 27, 2009
I wonder what the topic will be?
http://www.isobm2009.nl/program.html